Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects.

Apostolova LG, Hwang KS, Andrawis JP, Green AE, Babakchanian S, Morra JH, Cummings JL, Toga AW, Trojanowski JQ, Shaw LM, Jack CR Jr, Petersen RC, Aisen PS, Jagust WJ, Koeppe RA, Mathis CA, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2010 Aug;31(8):1284-303. doi: 10.1016/j.neurobiolaging.2010.05.003. Epub 2010 Jun 11.

2.

The clinical use of structural MRI in Alzheimer disease.

Frisoni GB, Fox NC, Jack CR Jr, Scheltens P, Thompson PM.

Nat Rev Neurol. 2010 Feb;6(2):67-77. doi: 10.1038/nrneurol.2009.215. Review.

3.

Mild cognitive impairment: ten years later.

Petersen RC, Roberts RO, Knopman DS, Boeve BF, Geda YE, Ivnik RJ, Smith GE, Jack CR Jr.

Arch Neurol. 2009 Dec;66(12):1447-55. doi: 10.1001/archneurol.2009.266. Review.

4.

The many faces of dementia.

Shagam JY.

Radiol Technol. 2009 Nov-Dec;81(2):153-68. Review.

PMID:
19901352
5.

Risk factors for dementia.

Chen JH, Lin KP, Chen YC.

J Formos Med Assoc. 2009 Oct;108(10):754-64. doi: 10.1016/S0929-6646(09)60402-2. Review.

6.

Regional rates of neocortical atrophy from normal aging to early Alzheimer disease.

McDonald CR, McEvoy LK, Gharapetian L, Fennema-Notestine C, Hagler DJ Jr, Holland D, Koyama A, Brewer JB, Dale AM; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2009 Aug 11;73(6):457-65. doi: 10.1212/WNL.0b013e3181b16431.

7.

Longitudinal pattern of regional brain volume change differentiates normal aging from MCI.

Driscoll I, Davatzikos C, An Y, Wu X, Shen D, Kraut M, Resnick SM.

Neurology. 2009 Jun 2;72(22):1906-13. doi: 10.1212/WNL.0b013e3181a82634.

8.

Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index.

Davatzikos C, Xu F, An Y, Fan Y, Resnick SM.

Brain. 2009 Aug;132(Pt 8):2026-35. doi: 10.1093/brain/awp091. Epub 2009 May 4.

9.

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease.

Jack CR Jr, Lowe VJ, Weigand SD, Wiste HJ, Senjem ML, Knopman DS, Shiung MM, Gunter JL, Boeve BF, Kemp BJ, Weiner M, Petersen RC; Alzheimer's Disease Neuroimaging Initiative.

Brain. 2009 May;132(Pt 5):1355-65. doi: 10.1093/brain/awp062. Epub 2009 Mar 31.

10.

Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition.

Leow AD, Yanovsky I, Parikshak N, Hua X, Lee S, Toga AW, Jack CR Jr, Bernstein MA, Britson PJ, Gunter JL, Ward CP, Borowski B, Shaw LM, Trojanowski JQ, Fleisher AS, Harvey D, Kornak J, Schuff N, Alexander GE, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2009 Apr 15;45(3):645-55.

11.

MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers.

Schuff N, Woerner N, Boreta L, Kornfield T, Shaw LM, Trojanowski JQ, Thompson PM, Jack CR Jr, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

Brain. 2009 Apr;132(Pt 4):1067-77. doi: 10.1093/brain/awp007. Epub 2009 Feb 27.

12.

Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.

Morra JH, Tu Z, Apostolova LG, Green AE, Avedissian C, Madsen SK, Parikshak N, Hua X, Toga AW, Jack CR Jr, Schuff N, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.

Hum Brain Mapp. 2009 Sep;30(9):2766-88. doi: 10.1002/hbm.20708.

13.

The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods.

Jack CR Jr, Bernstein MA, Fox NC, Thompson P, Alexander G, Harvey D, Borowski B, Britson PJ, L Whitwell J, Ward C, Dale AM, Felmlee JP, Gunter JL, Hill DL, Killiany R, Schuff N, Fox-Bosetti S, Lin C, Studholme C, DeCarli CS, Krueger G, Ward HA, Metzger GJ, Scott KT, Mallozzi R, Blezek D, Levy J, Debbins JP, Fleisher AS, Albert M, Green R, Bartzokis G, Glover G, Mugler J, Weiner MW.

J Magn Reson Imaging. 2008 Apr;27(4):685-91. doi: 10.1002/jmri.21049.

14.

Atrophy rates accelerate in amnestic mild cognitive impairment.

Jack CR Jr, Weigand SD, Shiung MM, Przybelski SA, O'Brien PC, Gunter JL, Knopman DS, Boeve BF, Smith GE, Petersen RC.

Neurology. 2008 May 6;70(19 Pt 2):1740-52. Epub 2007 Nov 21.

15.

Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI).

Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack CR, Jagust W, Trojanowski JQ, Toga AW, Beckett L.

Alzheimers Dement. 2005 Jul;1(1):55-66.

16.

Aging of the brain, entropy, and Alzheimer disease.

Drachman DA.

Neurology. 2006 Oct 24;67(8):1340-52. Review.

PMID:
17060558
17.

The Alzheimer's disease neuroimaging initiative.

Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack C, Jagust W, Trojanowski JQ, Toga AW, Beckett L.

Neuroimaging Clin N Am. 2005 Nov;15(4):869-77, xi-xii. Review.

18.

Differential aging of the medial temporal lobe: a study of a five-year change.

Raz N, Rodrigue KM, Head D, Kennedy KM, Acker JD.

Neurology. 2004 Feb 10;62(3):433-8.

PMID:
14872026
19.

Automatically parcellating the human cerebral cortex.

Fischl B, van der Kouwe A, Destrieux C, Halgren E, S├ęgonne F, Salat DH, Busa E, Seidman LJ, Goldstein J, Kennedy D, Caviness V, Makris N, Rosen B, Dale AM.

Cereb Cortex. 2004 Jan;14(1):11-22.

PMID:
14654453
20.

Dynamics of gray matter loss in Alzheimer's disease.

Thompson PM, Hayashi KM, de Zubicaray G, Janke AL, Rose SE, Semple J, Herman D, Hong MS, Dittmer SS, Doddrell DM, Toga AW.

J Neurosci. 2003 Feb 1;23(3):994-1005.

Supplemental Content

Support Center